The "try and fail" language is flawed when weight loss is used as the primary measure of success with lifestyle interventions ...

On July 18, 2025, Director Jeffrey S. Flier disclosed the sale of 11,136 shares of Scholar Rock( SRRK -0.68%) in an open ...

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

GLP-1 medications, on average, can cost individuals $1,000 per month if their employers do not provide insurance coverage, Andrea Grande, a principal at Brown & Brown, said ...

Dealmaking in Europe’s life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength ...

With federal subsidies set to expire and insurers forecasting higher premiums, Texans who buy their own health insurance may ...

CHICAGO — Tariffs, the rise of GLP-1 medications and concerns about ultra-processed foods (UPFs) remain some of the major ...

What I’m thinking, as someone who owns Eli Lilly for the Charitable Trust and who wishes I owned PepsiCo, is that there might ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

Mini meals with bite size portions are meant to appeal to people taking GLP-1 weight-loss drugs that reduce appetite.